Accession Number : ADA188255
Title : Long-Term Bioeffects of 435-MHz Radiofrequency Radiation on Selected Blood-Borne Endpoints in Cannulated Rats. Volume 4. Plasma Catecholamines.
Descriptive Note : Final rept. Oct 82-Jun 85,
Corporate Author : GEORGIA TECH RESEARCH INST ATLANTA
Personal Author(s) : Popovic, Vojin P ; Toler, James C ; Bonasera, Stephen J ; Popovic, Pava P ; Honeycutt, Clegg B
PDF Url : ADA188255
Report Date : Aug 1987
Pagination or Media Count : 119
Abstract : Two hundred adult male white rates (Sprague-Dawley) with chronically implanted aortic cannulas were randomly divided into two groups. Animals in the first group were exposed to low-level (1.0mW/sq cm) pulsed-wave 435-MHz radiofrequency radiation (RFR) for about 22 h daily, 7 days each week for 6 months. Animals in the second group were maintained under identical conditions but were not radiated. The aortic cannulas were used to draw microsamples (0.6 mL) of aortic blood from the unrestrained, unanesthetized rats on a cyclic schedule. Plasma catecholamine (nonrepinephrine, epinephrine, and dopamine) concentrations were determined by radioimmunoassays. Statistical analysis of the results did not indicate increased plasma catecholamine concentrations on radiation-exposed animals when compared to sham-exposed animals. Exposure to this nonionizing radiofrequency (RF) environment did not induce stresses that were manifested as an alteration in plasma hormones. Keywords: Radiation pollution; Hormones; Electromagnetic radiation; Radiofrequency radiation; Microwaves; Rats; Plasma Catecholamines; Radiation effects.
Descriptors : *BLOOD, *BLOOD PLASMA, *CATECHOLAMINES, *ELECTROMAGNETIC RADIATION, *MICROWAVES, *RADIATION EFFECTS, *RADIOFREQUENCY, *RATS, *STRESSES, ANIMALS, AORTA, BIOLOGY, CANNULATION, CONCENTRATION(COMPOSITION), CYCLES, DOPAMINE, EPINEPHRINE, EXPOSURE(GENERAL), HORMONES, LONG RANGE(TIME), LOW LEVEL, PLASMAS(PHYSICS), RADIATION, RADIOIMMUNOASSAY, SCHEDULING, STATISTICAL ANALYSIS
Subject Categories : Medicine and Medical Research
Medicine and Medical Research
Distribution Statement : APPROVED FOR PUBLIC RELEASE